YD Bio YDES
NASDAQ YDES
$4.24 -1.53 (-26.52%)
At close: Oct 22, 2026 · 4:00 PM EDT

YD Bio (YDES) Cash & Equivalents (2024 - 2026)

Updated

YD Bio (YDES) posted Cash & Equivalents of $2.66 million for the quarter ended Jun 30, 2026, up 467.0% from $469,520 a year earlier.

Analysis

YD Bio (YDES) Cash & Equivalents (2024 - 2026) Analysis & Trends

As of Dec 31, 2025, YD Bio's Cash & Equivalents came in at $6.01 million, up 91.8% from the prior year.

  • In prior years, YD Bio's Cash & Equivalents was $3.13 million in the year ended Dec 31, 2024.
  • Quarterly Cash & Equivalents has run from a low of $469,520 in the quarter ended Jun 30, 2025 to a high of $6.01 million in the quarter ended Dec 31, 2025 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 16.91 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 6.57 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 4.90 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 3.18 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 976.00 Mn
10 YD Bio 300.15 Mn 287.88 Mn - 2.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.66 Mn
Dec 31, 2025 6.01 Mn
Jun 30, 2025 469,520.00
Dec 31, 2024 3.13 Mn
API Access

YD Bio Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=YDES&period=max&api_key=YOUR_API_KEY